⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of DermaClip US, LLC and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
DermaClip US, LLC
↗Houston, USA
DermaClip US, LLC is a medical device company that manufactures the DermaClip® Skin Closure Device, a needle-free, non-invasive alternative to sutures, staples, and glues. The device is designed to optimize wound closure for surgical incisions and traumatic lacerations by providing sustained bilateral tension and skin eversion.
The company's technology is utilized across various medical settings, including emergency medicine, surgery, pediatrics, and geriatrics. DermaClip products are recognized for their ease of use, ability to reduce closure time, and clinical efficacy, and are currently included in federal supply schedules for use by the U.S. military and other health facilities.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Medical Device
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:DQ Holdings, LLC
Key Partnerships:U.S. Military (Department of Defense), McKesson Medical-Surgical (Distribution)
COMPETITION
Position:Niche Player
Competitors:Clozex Medical, Smith+Nephew
LEADERSHIP
Key Executives:
Charles Darling - CEO
Kirk Sanders - VP of Sales
LINKS
Website:dermaclip.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with DermaClip US, LLC. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.